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Open reading frame 3 (ORF 3) of equine arteritis virus (EAV) is predicted to encode a glycosylated membrane protein (GP3)
that is uncharacterized. ORF 3 of the American Type Culture Collection strain of EAV was in vitro transcribed and the encoded
GP3 protein was in vitro translated with and without canine microsomal membranes. The GP3 protein was approximately 17
kDa after in vitro translation without canine microsomal membranes whereas the glycosylated form, after translation with
microsomal membranes, was a diffuse band of 36–42 kDa, indicating that the GP3 protein is extensively glycosylated.
Deglycosylation reduced the GP3 protein to approximately 17 kDa, the same size as that translated without microsomal
membranes, indicating that the signal sequence was not cleaved. The EAV GP3 protein was membrane associated and not
released as a soluble protein, in marked contrast to the ORF 3-encoded proteins of some other arteriviruses. The GP3 protein
was protected from protease digestion in closed membrane vesicles, suggesting that the protein extends into the membrane
vesicles and is anchored by the N-terminal signal sequence, a C-terminal hydrophobic domain, or both, but does not span
the membrane three times. A GP3 protein lacking the C-terminal transmembrane domain remained membrane associated,
indicating that this terminus is not a necessary membrane anchor. Sera from stallions persistently infected with EAV and
horses immunized repeatedly with the modified live EAV vaccine contained antibodies specific for the GP3 protein. The data
indicate that the GP3 protein is an extensively glycosylated membrane protein that is immunogenic during some EAV
infections. © 1999 Academic Press
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aINTRODUCTION
Equine arteritis virus (EAV) is the prototype member of
he Arterivirus genus in the Arteriviridae family and the
idovirales order (Cavanagh, 1997). Other members of
he Arteriviridae family are porcine reproductive and
espiratory syndrome virus (PRRSV), lactate dehydroge-
ase elevating virus of mice (LDV), and simian hemor-
hagic fever virus (Meulenberg et al., 1994). The EAV
enome is a positive-stranded RNA of approximately
2.7 kb and includes nine open reading frames [ORFs;
Snijder et al., 1999; den Boon et al., 1991)]. ORFs 1a and
b are located within the 9.7 kb at the 59 end of the
enome and encode the viral replicase (den Boon et al.,
991). ORFs 2–7 overlap at their 39 and 59 ends and
ncode five structural proteins (Snijder et al., 1999; den
oon et al., 1991). The known EAV structural proteins (E,
S, GL, M, and N) are encoded by ORFs 2a, 2b, 5, 6, and
, respectively, and two putatively glycosylated but un-
haracterized proteins (GP3 and GP4) are encoded by
RFs 3 and 4 (Snijder et al., 1999; de Vries et al., 1992).
he ORFs 3 of all four arteriviruses are predicted to
ncode glycosylated membrane glycoproteins of similar
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athology, Microbiology and Immunology, School of Veterinary Medi-
ine, University of California, Davis, 1126 Haring Hall, Davis, CA 95616.dax: (530) 754-8124. E-mail: njmaclachlan@ucdavis.edu.
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92ize and structure (de Vries et al., 1997; Plagemann,
996).
EAV is the cause of equine viral arteritis (EVA), which
s characterized by an influenza-like illness of adult
orses, abortion in pregnant mares, and persistent in-
ection of stallions (Timoney and McCollum, 1993). Most
usceptible mares bred to persistently infected carrier
tallions become infected with EAV and may then spread
irus by aerosol to precipitate outbreaks of EVA (Timoney
nd McCollum, 1993). Genetic and phenotypic diversity
re generated during long-term EAV persistence in stal-
ions; thus the carrier stallion is critical to the epidemi-
logy of EAV infection (Hedges et al., 1999). High rates of
onsynonymous substitutions occurred in ORF 3 during
ong-term persistent infection of two carrier stallions,
ndicating that the GP3 protein was under strong selec-
ive pressure (Hedges et al., 1999). The ORF 3-encoded
roteins of LDV and PRRSV vary between field isolates
nd are immunogenic (Faaberg and Plagemann, 1997;
atz et al., 1995; Plana-Duran et al., 1998; Drew et al.,
997). The ORF 3-encoded protein of the Lelystad strain
f PRRSV is a structural protein, whereas those of the
eference Quebec strain of PRRSV (IAF-Klop) and of LDV
re nonstructural and secreted (van Nieuwstadt et al.,
996; Mardassi et al., 1998; Gonin et al., 1998; Faaberg
nd Plagemann, 1997). The goals of this study were to
etermine if the GP3 protein of EAV is a soluble or a
m
v
o
t
2
s
w
p
a
k
1
G
t
f
1
s
t
9
g
a
e
e
T
c
p
t
c
b
p
3
t
K
p
p
i
G
v
g
p
b
a
o
w
2
t
n
a
E
s
i
p
r
(
s
a
T
a
r
s
2
a
s
g
t
N
a
b
b
E
m
e
B
c
a
O
a
1
t
a
G
c
F
w
t
93ORF 3 OF EAV ENCODES AN IMMUNOGENIC MEMBRANE PROTEINembrane protein and whether EAV-infected horses de-
elop antibodies to this protein.
RESULTS AND DISCUSSION
ORF 3 of the ATCC strain of EAV contains 489 nucle-
tides and is predicted to encode a 163-amino-acid pro-
ein with six potential glycosylation sites at amino acids
8, 29, 49, 96, 106, and 118. The predicted amino acid
equence of the GP3 protein of the ATCC strain of EAV
as compared to the PROSITE database via the MOTIF
rogram (GenomeNet, Kyoto University, Japan; Bairoch et
l., 1997). The comparison also predicted three casein
inase II phosphorylation sites (amino acids 36, 70, and
29) and one myristoylation site (amino acid 23). The
P3 protein has a predicted signal sequence with po-
ential cleavage sites after amino acids 26 (G) and 27 (S),
ollowing the 23, 21 rule of von Heijne (Nielsen et al.,
997; von Heijne, 1988, 1990). Five of six programs de-
igned to predict transmembrane domains predicted
hree transmembrane domains at amino acids 4–26, 71–
9, and 137–162 in the GP3 protein, whereas one pro-
ram predicted only a single transmembrane domain at
mino acids 4–25 (Tusna´dy and Simon, 1998; Hirokawa
t al., 1998; Persson and Argos, 1994; 1996; Sonnhammer
t al., 1998; Hofmann and Stoffel, 1993; von Heijne, 1992).
o further characterize the EAV GP3 protein, ORF 3 was
loned, transcribed, and translated in vitro. The GP3
rotein was approximately 17 kDa after in vitro transla-
ion without canine microsomal membranes and the gly-
osylated form, after translation with microsomal mem-
ranes, was a diffuse band of 36–42 kDa (Fig. 1). The
redicted size of the fully glycosylated GP3 protein is
3.6 kDa, assuming each of the six predicted glycosyla-
ion sites adds 2.6 kDa to the core protein (Bergman and
uehl, 1982). It is likely, therefore, that each of the six
redicted glycosylation sites was utilized.
Comparison of the deglycosylated form of GP3 to the
rotein translated without microsomal membranes facil-
tated characterization of signal sequence cleavage. The
P3 protein was deglycosylated with Glyco-F after in
itro translation with microsomal membranes. The de-
lycosylated GP3 protein was the same size as the GP3
rotein translated without canine microsomal mem-
ranes, as determined by analysis in both 12 and 15%
crylamide gels (Fig. 1). Signal sequence cleavage at
ne of the predicted sites, after amino acid 26 or 27,
ould result in a deglycosylated protein of approximately
.7 kDa less than that translated without membranes;
hus, the data indicate that the GP3 signal sequence was
ot cleaved. There are two predicted N-linked glycosyl-
tion sites at residues N28 and N29 of the ATCC strain of
AV that, if utilized immediately, may interfere with the
ignal peptidase cleavage at these sites. In similar stud-
es, the signal sequence of the soluble ORF 3-encoded
rotein of LDV was also not cleaved, possibly due to the iapid glycosylation of N23 close to the signal sequence
Faaberg and Plagemann, 1997).
To further evaluate the influence of glycosylation on
ignal sequence cleavage, the glycosylation sites at N28
nd N29 were altered by site-directed mutagenesis.
hree different mutants were constructed that altered
mino acids 28 to 31 (NNTT) to AATT, NATT, and ANTT,
espectively. After in vitro translation with canine micro-
omal membranes the AATT mutant was approximately
8 kDa and the NATT and ANTT mutants were both
pproximately 33 kDa, indicating that both glycosylation
ites were utilized in the original GP3 protein and that
lycosylation at these sites was effectively abrogated in
he mutant proteins. The lack of glycosylation of N28 and
29 had no obvious effect on the signal sequence cleav-
ge and membrane association of the mutants, as each
ehaved like the parental GP3 protein (data not shown).
To investigate whether the EAV GP3 protein is mem-
rane associated or soluble, ORF 3 of the ATCC strain of
AV was translated in vitro in the presence of canine
icrosomal membranes, incubated in two different buff-
rs, and centrifuged to separate the membrane pellets.
acterial b-lactamase was used as a soluble protein
ontrol (Promega; Koshland and Botstein, 1980; Dalbey
nd von Heijne, 1992). The EAV M protein, encoded by
RF 6, spans the membrane three times and was used
s an integral membrane protein control (de Vries et al.,
992). The various proteins were incubated in either
FIG. 1. SDS–PAGE analysis of the in vitro translated GP3 and b-lac-
amase proteins. The proteins were translated in the presence (1) or
bsence (2) of canine microsomal membranes and either treated with
lyco-F (1) or mock-treated (2). The reduced size of the b-lactamase
ontrol is indicative of signal sequence cleavage, whereas the Glyco
-treated GP3 protein was the same size as that translated in vitro
ithout microsomal membranes, indicating that the signal sequence of
he GP3 protein is not cleaved.sotonic Tris-buffered sucrose (pH 7.5) or carbonate
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94 HEDGES, BALASURIYA, AND MACLACHLANuffer (pH 11.5) after in vitro translation. The microsomal
embrane vesicles remain closed in the sucrose buffer
o that both integral membrane proteins and secreted
roteins remain in the membrane pellet after centrifuga-
ion. In contrast, the carbonate buffer perforates the
embrane vesicles so that only integral membrane pro-
eins remain in the membrane pellet after centrifugation
nd soluble proteins are released into the supernatant.
roteins lacking a signal sequence and translated on
ree ribosomes are always found in the supernatant, as
ere the GP3 and M proteins after translation without
icrosomal membranes (data not shown). The soluble
-lactamase protein was associated with the membrane
ellet after in vitro translation and incubation in the
sotonic sucrose buffer, although some protein leaked
nto the supernatant (Fig. 2C), likely because the com-
ercial source of canine microsomal membranes does
ot control for closed membranes and the incubation
ime in the two buffers was greatly extended relative to
escribed protocols (Faaberg and Plagemann, 1997).
hen incubated in the carbonate buffer, however, the
-lactamase protein was dissociated from the mem-
ranes and recovered in the supernatant (Fig. 2C). In
ontrast, the GP3 protein remained associated with the
embrane pellet as did the M protein after in vitro
ranslation with microsomal membranes and incubation
n either buffer (Figs. 2A and 2B). These data unequivo-
ally show that the GP3 protein of the ATCC strain of EAV
s membrane associated and is not released into the
upernatant as a soluble protein. These results contrast
arkedly with those described for the ORF 3-encoded
rotein of LDV, which was completely soluble, and for the
P3 protein of the IAF-Klop strain of PRRSV, which was
ound in a membrane-free soluble form in the tissue
ulture fluid of PRRSV-infected cultured cells (Faaberg
nd Plagemann, 1997; Mardassi et al., 1998; Gonin et al.,
998). The membrane-associated GP3 protein of EAV,
herefore, is more similar to that of the Lelystad strain of
RRSV than to those of the IAF-Klop strain of PRRSV and
f LDV.
Protease protection experiments were done to assess
he membrane orientation of the GP3 protein. After in
itro translation with microsomal membranes and incu-
ation in either buffer, the pelleted fraction was digested
ith trypsin or chymotrypsin and analyzed by SDS–
AGE. Digestion with either protease did not alter the
lectrophoretic mobility of the GP3 protein after incuba-
ion in the isotonic buffer (Fig. 3). When the vesicles were
erforated by incubation in carbonate buffer, the result-
ng protease-digested GP3 protein migrated at approxi-
ately 26 kDa. The 26-kDa protein likely represents a
rotease-protected transmembrane domain, perhaps
ith a glycosylated extension lacking specific protease
leavage sites. The M protein, which spans the mem-
rane three times, was reduced to approximately 14 kDa
fter incubation in either buffer, suggesting that a domain censitive to protease digestion extends outside the
losed vesicles (Fig. 3). These data suggest that little or
one of the GP3 protein extends to the exterior of the
losed vesicles. The GP3 protein is, therefore, likely
nchored either by the N-terminal signal sequence or by
he C-terminal hydrophobic region, or by both, and ex-
ends into the membrane vesicles. A triple spanning
embrane protein is precluded because of its protease
esistance in closed vesicles as well as the highly gly-
FIG. 2. Characterization of the membrane association of the GP3
rotein after in vitro translation. The GP3 protein (A) is highly membrane
ssociated as it remains in the membrane pellet (P) after incubation
nder either isotonic (Tris–sucrose) or nonisotonic (carbonate) condi-
ions, as does the M protein (B). In contrast, the secreted b-lactamase
ontrol (C) is present in the supernatant (S) after incubation in noniso-
onic buffer.osylated nature of the GP3 protein.
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95ORF 3 OF EAV ENCODES AN IMMUNOGENIC MEMBRANE PROTEINMembrane proteins with N-terminal signal peptides
re inserted into the endoplasmic reticulum membrane
n a hairpin formation as they are translated. The N-
erminus of the signal sequence remains in the cyto-
lasm and the C-terminus of the signal sequence is
xposed to signal peptidase in the lumen of the endo-
lasmic reticulum. If signal sequence cleavage occurs,
he protein either becomes soluble or remains anchored
o the membrane by a downstream transmembrane do-
ain. When the signal sequence is not cleaved, it re-
ains in the membrane and anchors the protein, result-
ng in a Class II membrane protein that is anchored by
he uncleaved signal sequence (von Heijne, 1988, 1990).
ur data suggest that the EAV GP3 protein produced by
n vitro translation with microsomal membranes is either
Class II integral membrane protein anchored by the
ncleaved signal sequence or a Class IV membrane
rotein anchored by both the signal sequence and the
-terminal transmembrane domain.
A C-terminal deletion mutant was constructed to de-
ermine if the hydrophobic C-terminus is necessary as a
embrane anchor. An oligonucleotide primer was de-
igned that introduced a stop codon after amino acid 142
f the GP3 protein, thus deleting the C-terminal potential
ydrophobic transmembrane domain. The protein prod-
ct lacking the C-terminal transmembrane domain re-
ained its N-terminal signal sequence and remained
embrane associated after incubation in either the Tris–
ucrose or the sodium carbonate buffers (data not
hown). Thus, the C-terminal transmembrane domain is
ot necessary for membrane association of the GP3
rotein.
Fifty-two equine sera were screened for their ability to
mmunoprecipitate the in vitro translated GP3 protein.
FIG. 3. Determination of the membrane orientation of the GP3 protein
ranslation with canine microsomal membranes and incubation in differe
hat the GP3 protein is protected in closed vesicles (lanes 2 and 3) but
rotein is sensitive to the protease digestion after incubation in eitherncluded were 5 sera that did not contain EAV-specific hntibodies, sera from 9 mares and geldings that previ-
usly had been experimentally infected with EAV, sera
rom 5 naturally infected mares, and sera from 22 natu-
ally infected stallions, 16 of which were persistently
nfected and 6 of which had not become persistently
nfected after acute EAV infection (Table 1). Also included
ere 10 sera from thoroughbred stallions annually vac-
inated multiple times with the live attenuated virus vac-
ine (ARVAC, Ft. Dodge Laboratories). All seropositive
era precipitated the in vitro translated M protein,
hereas the negative sera did not (data not shown).
hirteen of sixteen (81.3%) sera from carrier stallions and
ll (10/10) of the sera from vaccinated horses precipi-
ated the GP3 protein to varying degrees (Fig. 4, Table 1).
n contrast, only 4 of 20 (20%) sera from nonpersistently
nfected EAV-seropositive horses very weakly precipi-
ated the GP3 protein. These data suggest that ongoing
r repeated exposure to replicating virus facilitates gen-
ration of an immune response to the GP3 protein. The
P3 protein is clearly immunogenic during some EAV
nfections of the horse.
These data indicate that the GP3 protein of the ATCC
train of EAV is a glycosylated integral membrane protein
ikely anchored by the uncleaved N-terminal signal se-
uence and possibly also by a C-terminal hydrophobic
omain. Thus, the EAV GP3 protein is more similar to that
f the Lelystad strain of PRRSV in which it is a structural
rotein than to the soluble ORF 3-encoded proteins of
DV or the IAF-Klop strain of PRRSV. Although EAV is the
rototype member of the Arterivirus genus, the biochem-
cal behavior of the EAV GP3 protein is not indicative of
he entire genus. The potential glycosylation sites near
he predicted GP3 signal sequence cleavage site are
tilized on the native protein, but mutation of these sites
ase or mock treatment (lanes 1 and 6) of the GP3 and M proteins after
ering conditions (isotonic sucrose and nonisotonic carbonate) indicate
ve to proteases in perforated vesicles (lanes 4 and 5), whereas the M
(lanes 7–10).. Prote
nt buff
sensitiad no obvious effect on signal sequence cleavage. The
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96 HEDGES, BALASURIYA, AND MACLACHLANignal sequence region of the GP3 protein was highly
ariable, and hydrophobicity of the amino acids in this
egion also varied during long-term persistent EAV infec-
ion of carrier stallions and among seven field isolates of
AV (Hedges et al., 1999; Archambault et al., 1997). Mem-
rane association of the GP3 protein might differ be-
ween strains and reflect variation in hydrophobicity of
he signal sequence or signal peptidase cleavage sites.
he GP3 protein was also under selective pressure dur-
ng persistent EAV infection of carrier stallions (Hedges
t al., 1999), and horses clearly develop antibodies to the
P3 protein after repeated vaccination or persistent EAV
nfection. The role of the GP3 protein during EAV infec-
T
Immunoprecipitation of the in Vitro Tra
Neutralization assay
negative sera
Experimental
infectionsa i
otal sera 6 9
era that precipitated
the M protein
0 9
era that precipitated
the GP3 protein
0 2b
ercentage of sera
that precipitated
the GP3 protein
0.0% 22.2%
a Geldings and mares.
b Positive reactions were weak positives.
FIG. 4. Immunoprecipitation of in vitro translated GP3 protein by
elected sera from a vaccinated horse (VAC), two carrier stallions, and
seropositive noncarrier stallion and by a serum that did not containcntibodies to EAV (NEG).ion and persistence in horses, however, remains to be
haracterized.
MATERIALS AND METHODS
The ATCC strain of EAV (ATCC VR-796) was passaged
n rabbit kidney cells (ATCC CCL 37) and total RNA was
urified as previously described (Balasuriya et al.,
995b). The entire ORFs 3 and 6, which encode the GP3
nd M proteins, respectively, were RT–PCR amplified
sing degenerate primers (named for the location on the
AV genome to which the 59 end of the primer binds
nd the restriction site contained within the primer,
espectively; ORF 3 primers, 10260 EcoRI 59CATCTAGC-
AATTCGACCGGAC39 and 10795 BamHI 59GTGGCCG-
ATCCATGAC39; ORF 6 primers, 12459 EcoRI 59TCCT-
TTGAATTCAATCATGCC39 and 11852 XhoI 59GTCAAC-
TCGAGAGGTTGG39) with restriction sites matching
hose in the multiple cloning site of the plasmid
cDNA3.12 (Invitrogen). A C-terminal deletion mutant of
P3 was also cloned into plasmid pcDNA3.12 after PCR
mplification with a degenerate primer (10688 BamHI
9GGATCCTACCTAATATGCAGCCGTAGATC39) designed
o insert a stop codon after amino acid 142 and add the
ppropriate restriction site. Site-directed mutagenesis of
he whole ORF 3 at the amino acid codons 28–31 (NNTT)
as performed as follows. Degenerate primers (10364
ATT 59CAAATAGTAGTAGCAGCGCTGCC39, 10364 NATT
9CAAATAGTAGTAGCATTGCTGCC39, and 10361 ANTT
9GTAGTATTAGCGCTGCCAAC39) in the negative orien-
ation were designed to encode changes in amino acids
8–31 (NNTT) to AATT, NATT, and ANTT, respectively.
CR reactions were performed using these primers
aired with the 10260 EcoRI primer using the cloned ORF
as a template, resulting in an approximately 100-bp
roduct. This 100-bp product was gel purified (Qiagen)
nd used as the primer for the second PCR along with
he 10795 BamHI primer, using the cloned ORF 3 as the
emplate. This mutated PCR product was gel purified and
M and GP3 Proteins by Equine Sera
rally
mares
Naturally infected
noncarrier stallions
Naturally infected
carrier stallions
Vaccinated
horses
6 16 10
6 16 10
1b 13 10
0% 16.7% 81.3% 100.0%ABLE 1
nslated
Natu
nfected
5
5
1b
20.loned into pcDNA3.12. All PCR products were cloned in
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97ORF 3 OF EAV ENCODES AN IMMUNOGENIC MEMBRANE PROTEINhe correct orientation downstream from a T7 promoter
sing standard protocols and determined by automatic
equencing, as previously described (Sambrook et al.,
989; Hedges et al., 1996). The plasmids were linearized
t a unique restriction enzyme site at the 39 end of the
ene, purified twice with phenol:chloroform:isoamyl al-
ohol (25:24:1), and precipitated with ethanol. In vitro
ranscription was performed with 0.5 mM rNTP and 75 U
Nase inhibitor (RNAguard, Pharmacia), 50 U of T7 RNA
olymerase, 13 T7 transcription buffer, 5 mM DTT, 5 mg
SA (Promega), and 2 mM Cap analog (New England
iolabs) in 50-ml reaction volumes. Transcripts were pu-
ified by lithium chloride precipitation and analyzed on
Nase-free 1% agarose gels. The transcribed RNAs were
hen translated in vitro in rabbit reticulocyte lysates (Pro-
ega) in reaction volumes of 25 ml with [35S]methionine
NEN Life Sciences) as described by the supplier and by
aaberg et al. (1997). Where indicated, 2 ml of canine
icrosomal membranes (Promega) was included in the
eaction.
Membrane association of the in vitro translated GP3
rotein and the various mutant proteins was character-
zed essentially as described by Faaberg and Plage-
ann (1997). The in vitro translated EAV M protein and
he b-lactamase protein (b-lactamase RNA supplied by
romega) were used for comparison. Briefly, in vitro
ranslation reactions were suspended in 0.45 ml of either
ris-buffered sucrose (pH 7.5) or 100 mM sodium carbon-
te (pH 11.5) and incubated overnight at 4°C. The sam-
les were centrifuged; pelleted microsomal membranes
nd associated proteins were washed with sterile water
nd air-dried. Proteins remaining in the supernatant
ere precipitated using trichloroacetic acid; protein pel-
ets were washed with acetone and air-dried (Cabib and
olacheck, 1984). Pelleted microsomal membranes and
recipitated supernatant protein pellets were resus-
ended in Laemmli sample buffer (0.5 M Tris–HCl, pH
.8, 20% glycerol, 20% SDS, and 0.5% bromophenol blue)
nd analyzed by polyacrylamide gel electrophoresis
SDS–PAGE) with both 12 and 15% Tris–HCl Ready Gels
Bio-Rad; Laemmli, 1970).
Proteins were deglycosylated by resuspending the in
itro translation reaction mix in 100 ml of endoglycosi-
ase buffer (50 mM sodium phosphate, pH 6.8, 20 mM
DTA, 1% NP-40, 0.15% SDS, 1% b-mercaptoethanol, and
he protease inhibitors aprotinin, leupeptin, and pepsta-
in A at 1 mg/ml, and PMSF at 5 mg/ml), adding 200 mU
ndoglycosidase F/N-glycosidase F (Glyco-F; Boehr-
nger Mannheim Inc.), and incubating at 30°C for 16 h in
shaking incubator. Products were analyzed by SDS–
AGE. Trypsin and chymotrypsin (Boehringer Mannheim
nc.) treatments were performed essentially as described
y Faaberg et al. (1995). After 1-h incubations in either
rotease, an equal volume of 23 sample buffer with
rotease inhibitors was added and the products were
nalyzed by SDS–PAGE.To assess immunogenicity of the GP3 protein in EAV-
nfected horses, a large panel of sera from naturally and
xperimentally EAV-infected horses, including persis-
ently infected carrier stallions and horses that had been
accinated multiple times, were screened for their ability
o immunoprecipitate the GP3 protein (Table 1; Hedges
t al., 1998). Immunoprecipitation assays were carried
ut essentially as previously described (Balasuriya et al.,
995a). Briefly, after in vitro transcription with microsomal
embranes, 0.5 ml of immunoprecipitation buffer (20
M Tris–HCl, pH 7.6, 150 mM NaCl, 5 mM EDTA, 0.5%
P-40, 0.01% sodium deoxycholate, 0.1% SDS, and the
rotease inhibitors aprotinin, leupeptin, and pepstatin A
t 1 mg/ml and PMSF at 5 mg/ml) and 15 ml of equine
erum were added to the in vitro translation reaction and
he mixture was incubated at 4°C overnight. Following
he overnight incubation, 30 ml of a 50% suspension of
rotein G–Sepharose (Zymed Inc.) was added and the
amples were incubated for 3 h at 4°C. Immune com-
lexes were collected by centrifugation and washed
hree times with Buffer I (20 mM Tris–HCl, pH 7.6, 150
M NaCl, 5 mM EDTA, 0.5% NP-40) and once with Buffer
I (20 mM Tris–HCl, pH 7.6, 0.1% NP-40). The immunopre-
ipitated proteins were resuspended in Laemmli sample
uffer and analyzed by SDS–PAGE.
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